| Financial Year |
March 31 2023 |
| Monetary Funds |
280,293,990.69 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
259,427,080.02 |
| Advances to Suppliers |
5,415,121.97 |
| Other Receivables |
12,179,553.36 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
481,171,777.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
41,429,109.80 |
| Total Current Assets |
1,176,887,766.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
71,331,476.30 |
| Investment Properties |
-- |
| Fixed Assetes |
501,899,934.39 |
| Under-construction Projects |
952,163,065.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
126,843,929.78 |
| R&D expenses |
18,752,173.42 |
| Goodwill |
9,414,785.30 |
| Long-Term Deferred and Prepaid Expenses |
3,798,689.82 |
| Deferred Income Tax Assets |
27,105,106.05 |
| Other Non-Current Assets |
16,941,805.75 |
| Sub-Total of Non-Current Assets |
1,764,137,117.73 |
| Total Assets |
2,941,024,884.23 |
| Short-Term Loans |
260,193,200.69 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
31,761,502.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,371,952.11 |
| Taxes Payable |
5,512,190.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
55,723,799.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,519,526.87 |
| Other Current Liabilities |
702,465.75 |
| Sub-Total of Current Liabilities |
377,689,613.26 |
| Long-term Loans |
189,568,652.59 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
15,877,153.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
213,056,935.99 |
| Total Liabilities |
590,746,549.25 |
| Paid-In Capital(Or Share Stock) |
1,050,276,214.00 |
| Capital Surplus |
493,497,206.49 |
| Surplus Reserve |
51,831,774.20 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
723,770,866.78 |
| Minority Stockholder's Interest |
28,397,178.91 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,321,881,156.07 |
| Owner's Equity（Stockholder's Equity） |
2,350,278,334.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,941,024,884.23 |
